查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2129342

全球生物感測器市場預測至2034年：按產品類型、技術、應用、最終用戶和地區分類

Biosensor Market Forecasts to 2034 - Global Analysis By Product Type (Wearable Biosensors and Non-Wearable Biosensors), Technology, Application, End User, and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 預測，全球生物感測器市場預計將在 2026 年達到 378 億美元，並在預測期內以 8.3% 的複合年成長率成長，到 2034 年達到 716 億美元。

生物感測器是一種分析儀器，它結合了生物識別元件和物理化學轉化元件，用於檢測和測量特定的生物、化學或物理分析物。這些儀器將生物反應轉化為可測量的訊號，從而實現對目標物質的快速、高靈敏度和特異性檢測。其市場應用範圍廣泛，包括醫療診斷、食品安全與品質檢測、生物製程監控、農業、環境監測等。終端使用者包括醫院和診斷實驗室、居家醫療、研究和學術機構、製藥和生物技術公司、食品和飲料公司、農業組織、環境監測機構、安全和生物防禦機構等。

慢性病盛行率不斷上升以及對早期診斷的需求日益成長

全球慢性疾病負擔日益加重，例如糖尿病、心血管疾病和癌症，加上對早期診斷和疾病管理的需求不斷成長，這些都是推動生物感測器市場發展的關鍵因素。生物感測器能夠快速、準確且經濟高效地檢測疾病生物標記物，從而促進早期療育並改善患者預後。糖尿病盛行率的上升推動了對血糖值監測設備的需求。心血管疾病監測和癌症生物標記檢測的應用領域也不斷擴展。隨著醫療保健系統日益重視預防醫學和早期檢測，生物感測器在臨床、家庭護理和即時檢測環境中的應用也不斷擴大。

嚴格的法規核准要求和品質標準

醫療生物感測器複雜的監管環境以及臨床應用所需的嚴格品質標準對市場構成了重大限制。醫療生物感測器需要獲得監管部門的批准，而這些要求因司法管轄區而異。臨床檢驗試驗耗時且耗力。品管和生產標準，包括ISO和FDA的要求，都增加了營運負擔。新型生物感測器技術的核准流程可能漫長且不確定性。這些法規和品質要求可能會延遲產品上市，並限制中小企業的市場准入。

奈米技術和穿戴式生物感測器的進展

奈米技術、穿戴式技術和微流體技術的持續創新為生物感測器市場的擴張創造了巨大機會。金奈米顆粒、奈米碳管和石墨烯等奈米材料正在提高生物感測器的靈敏度和特異性。用於持續健康管理的穿戴式生物感測器，例如用於監測血糖值、乳酸水平和水合狀態的感測器，正日益受到關注。軟性可拉伸生物感測器的設計催生了新的應用。生物感測器與智慧型手機和數位健康平台的整合提高了使用的便利性。隨著技術的進步和成本的降低，新的生物感測器應用正在擴大市場佔有率並拓展目標市場。

與替代診斷技術的競爭

來自免疫檢測、分子診斷和檢查室檢測等替代診斷技術的競爭，對生物感測器市場的成長構成重大威脅。傳統診斷方法可能已獲得臨床認可並納入健保報銷系統。檢查室檢測提供全面的分析能力。生物感測器的開發和商業化成本可能很高。製造商可能會針對特定應用選擇成熟技術。這種競爭可能會限制生物感測器的應用，尤其是在臨床環境中，因為成熟方法更受青睞。

新型冠狀病毒（COVID-19）的影響：

新冠疫情對生物感測器市場產生了重大影響。疫情加速了對快速即時診斷檢測的需求，推動了生物感測器的創新和應用。用於感染疾病檢測的生物感測器，包括抗原檢測和分子檢測，需求空前高漲。疫情凸顯了快速便捷診斷的重要性。對生物感測器技術研發的投資顯著增加。即使在疫情過後，對快速診斷和疫情防治的關注依然持續，生物感測器在感染疾病檢測和控制中發揮核心作用。

在預測期內，醫療診斷領域預計將佔據最大的市場佔有率。

預計在預測期內，醫療診斷領域將佔據最大的市場佔有率，這主要得益於慢性病的高發生率、對早期診斷日益成長的需求以及生物感測器在臨床醫學中的廣泛應用。醫療診斷生物感測器包括血糖監測儀、心臟標記、傳染病檢查和癌症生物標記。該領域受益於臨床實踐中已建立的廣泛認可、診斷測試的保險報銷以及在醫療點應用的日益普及。隨著醫療保健系統越來越重視預防醫學和早期檢測，預計醫療診斷將在整個預測期內保持最大的應用領域佔有率。

預計在預測期內，居家醫療領域將實現最高的複合年成長率。

在預測期內，受自我監測設備需求成長、需要監測的慢性病盛行率上升以及穿戴式健康技術日益普及的推動，居家醫療領域預計將呈現最高的成長率。居家醫療生物感測器使患者無需前往醫療機構即可監測血糖值、心臟功能和其他健康參數。該領域正受益於小型化和互聯互通的技術進步。消費者對便捷易用的醫療保健解決方案的偏好也推動了其成長。隨著慢性病盛行率的上升和醫療保健模式向以患者為中心的方向轉變，居家醫療在終端用戶領域中實現了最快的成長。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這主要得益於其高昂的醫療費用支出、健全的監管體係以及成熟生物感測器技術的廣泛應用。美國正透過對醫療設備創新的大量投資推動區域市場成長。慢性病的高發生率刺激了對生物感測器的需求。完善的醫療保健基礎設施和保險報銷系統也為生物感測器的應用提供了支援。眾多生物感測器製造商和研究機構的存在推動了創新。高昂的醫療費用支出和技術領先優勢確保了北美在市場上的主導地位。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於醫療保健支出增加、慢性病患病率上升、早期診斷意識增強以及包括中國、印度、澳大利亞和東南亞在內的各國醫療保健基礎設施不斷完善。該地區龐大且持續成長的人口對診斷解決方案的需求龐大。各國政府正加強推動醫療保健現代化。可支配收入的成長也為醫療保健領域的投資提供了支持。即時檢測和居家醫療技術的日益普及推動了對生物感測器的需求。隨著醫療保健服務的可近性不斷提高以及診斷技術的進步，亞太地區正成為全球成長最快的生物感測器市場。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶要求，我們可以提供主要國家的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管/政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章 全球生物感測器市場：依產品類型分類

  • 穿戴式生物感測器
    • 感應器貼片
    • 腕戴式生物感測器
    • 智慧型手錶整合生物感測器
    • 其他穿戴式生物感測器
  • 非穿戴式生物感測器
    • 用於即時檢測的生物感測器
    • 實驗室生物感測器
    • 桌上型生物感測器
    • 嵌入式生物感測器
    • 可攜式手持生物感測器

第6章 全球生物感測器市場：依技術分類

  • 電化學生物感測器
    • 安培生物感測器
    • 電位生物感測器
    • 電導型生物感測器
    • 電阻型生物感測器
  • 光學生物感測器
    • 螢光感測器
    • 表面等離子體共振（SPR）生物感測器
    • 光纖生物感測器
    • 比色生物感測器
  • 壓電感測器
  • 熱生物感測器
  • 奈米機械生物感測器
  • 其他

第7章 全球生物感測器市場：按應用分類

  • 醫學診斷
    • 血糖值監測
    • 膽固醇檢測
    • 血氣分析
    • 妊娠和不孕症檢查
    • 感染疾病檢測
    • 癌症和腫瘤標記的檢測
    • 心血管疾病監測
    • 腎臟疾病監測
    • 藥物發現和藥物開發
    • 其他
  • 食品安全與品質檢驗
    • 檢測食品中的有害物質
    • 病原體檢測
    • 污染物檢測
    • 食品品質監測
  • 生物過程和生物反應器的監測
  • 在農業領域的應用
    • 土壤監測
    • 監測作物健康狀況
    • 植物病害檢測
    • 農藥及殘留物檢測
  • 環境監測
    • 水質監測
    • 空氣品質監測
    • 污染物檢測
  • 其他

第8章 全球生物感測器市場：依最終用戶分類

  • 醫院/診斷檢查室
  • 家庭醫療保健
  • 研究機構和學術機構
  • 製藥和生物技術公司
  • 食品和飲料公司
  • 農業組織
  • 環境監測組織
  • 安全與生物防禦局
  • 其他

第9章 全球生物感測器市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第10章 戰略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第11章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟、合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第12章：公司簡介

  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Medtronic plc
  • Bio-Rad Laboratories, Inc.
  • Johnson & Johnson
  • Siemens Healthineers AG
  • Danaher Corporation
  • Becton, Dickinson and Company
  • Thermo Fisher Scientific Inc.
  • Nova Biomedical
  • Dexcom, Inc.
  • LifeScan, Inc.
  • ACON Laboratories, Inc.
  • Universal Biosensors, Inc.
  • Nemaura Medical, Inc.
  • TE Connectivity Ltd.
  • Koninklijke Philips NV
  • Biosensors International Group, Ltd.
Product Code: SMRC39440

According to Stratistics MRC, the Global Biosensor Market is accounted for $37.8 billion in 2026 and is expected to reach $71.6 billion by 2034 growing at a CAGR of 8.3% during the forecast period. Biosensors are analytical devices that combine a biological recognition element with a physicochemical transducer to detect and measure specific biological, chemical, or physical analytes. These devices translate biological responses into measurable signals, enabling rapid, sensitive, and specific detection of target substances. The market encompasses applications across medical diagnostics, food safety and quality testing, bioprocess monitoring, agricultural applications, environmental monitoring, and other applications. End users include hospitals and diagnostic laboratories, home healthcare, research laboratories and academic institutions, pharmaceutical and biotechnology companies, food and beverage companies, agricultural organizations, environmental monitoring organizations, security and biodefense organizations, and other end users.

Market Dynamics:

Driver:

Growing prevalence of chronic diseases and demand for early diagnosis

The increasing global burden of chronic diseases including diabetes, cardiovascular disease, and cancer, coupled with the growing demand for early diagnosis and disease management, is a primary driver for the biosensor market. Biosensors enable rapid, accurate, and cost-effective detection of disease biomarkers, facilitating early intervention and improved patient outcomes. The rising prevalence of diabetes is driving demand for blood glucose monitoring devices. Cardiovascular disease monitoring and cancer biomarker detection are expanding applications. As healthcare systems emphasize preventive care and early detection, biosensor adoption continues growing across clinical, home, and point-of-care settings.

Restraint:

Stringent regulatory approval requirements and quality standards

The complex regulatory landscape governing medical biosensors and the rigorous quality standards required for clinical applications represent a major restraint for the market. Medical biosensors require regulatory approval, with varying requirements across jurisdictions. Clinical validation studies are time-consuming and expensive. Quality control and manufacturing standards including ISO and FDA requirements add operational burden. The approval process for novel biosensor technologies can be lengthy and uncertain. These regulatory and quality requirements may delay product launches and limit market entry for smaller companies.

Opportunity:

Advancements in nanotechnology and wearable biosensors

Continuous innovation in nanotechnology, wearable technology, and microfluidics presents significant opportunities for biosensor market expansion. Nanomaterials including gold nanoparticles, carbon nanotubes, and graphene are enhancing biosensor sensitivity and specificity. Wearable biosensors for continuous health monitoring including glucose, lactate, and hydration monitoring are gaining traction. Flexible and stretchable biosensor designs are enabling new applications. The integration of biosensors with smartphones and digital health platforms is expanding accessibility. As technology advances and costs decline, novel biosensor applications capture growing market share, expanding the addressable market.

Threat:

Competition from alternative diagnostic technologies

Competition from alternative diagnostic technologies including immunoassays, molecular diagnostics, and laboratory-based testing poses significant threats to biosensor market growth. Traditional diagnostic methods may offer established clinical acceptance and reimbursement. Laboratory-based testing provides comprehensive analysis capabilities. The cost of biosensor development and commercialization can be high. Manufacturers may choose established technologies for certain applications. This competition may limit biosensor adoption, particularly in clinical settings where established methods are preferred.

Covid-19 Impact:

The COVID-19 pandemic had a significant impact on the biosensor market. The pandemic accelerated demand for rapid, point-of-care diagnostic testing, driving biosensor innovation and adoption. Biosensors for infectious disease detection including antigen and molecular tests experienced unprecedented demand. The pandemic highlighted the importance of rapid, accessible diagnostics. Investment in biosensor technology development increased significantly. Post-pandemic, the focus on rapid diagnostics and pandemic preparedness continues, with biosensors playing a central role in infectious disease detection and management.

The Medical Diagnostics segment is expected to be the largest during the forecast period

The Medical Diagnostics segment is expected to account for the largest market share during the forecast period, driven by the high prevalence of chronic diseases, increasing demand for early diagnosis, and the wide range of biosensor applications in clinical medicine. Medical diagnostics biosensors include glucose monitoring devices, cardiac markers, infectious disease tests, and cancer biomarkers. The segment benefits from established clinical acceptance, reimbursement for diagnostic testing, and growing point-of-care adoption. As healthcare systems emphasize preventive care and early detection, medical diagnostics maintain the largest application segment share throughout the forecast period.

The Home Healthcare segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Home Healthcare segment is predicted to witness the highest growth rate, fueled by the growing demand for self-testing devices, increasing prevalence of chronic diseases requiring monitoring, and the rising adoption of wearable health technologies. Home healthcare biosensors enable patients to monitor glucose, cardiac function, and other health parameters without clinical visits. The segment benefits from technological advancements in miniaturization and connectivity. Consumer preference for convenient, accessible healthcare solutions supports adoption. As chronic disease prevalence increases and healthcare shifts toward patient-centered care, home healthcare delivers the fastest end-user segment growth.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, supported by high healthcare spending, strong regulatory infrastructure, and established biosensor technology adoption. The United States leads regional market growth with substantial investment in medical device innovation. High prevalence of chronic diseases drives biosensor demand. Well-established healthcare infrastructure and reimbursement systems support adoption. Strong presence of biosensor manufacturers and research institutions drives innovation. With high healthcare spending and technology leadership, North America maintains its dominant market position.

Region with highest CAGR:

Over the forecast period, the Asia-Pacific region is anticipated to exhibit the highest CAGR, driven by rising healthcare spending, increasing prevalence of chronic diseases, growing awareness of early diagnosis, and expanding healthcare infrastructure across countries including China, India, Australia, and Southeast Asia. The region's large and growing population creates substantial demand for diagnostic solutions. Government healthcare modernization initiatives are expanding. Rising disposable incomes support healthcare investment. Increasing adoption of point-of-care and home healthcare technologies drives biosensor demand. As healthcare access improves and diagnostic technology adoption grows, Asia Pacific delivers the fastest biosensor market growth globally.

Key players in the market

Some of the key players in Biosensor Market include Abbott Laboratories, F. Hoffmann-La Roche Ltd., Medtronic plc, Bio-Rad Laboratories, Inc., Johnson & Johnson, Siemens Healthineers AG, Danaher Corporation, Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Nova Biomedical, Dexcom, Inc., LifeScan, Inc., ACON Laboratories, Inc., Universal Biosensors, Inc., Nemaura Medical, Inc., TE Connectivity Ltd., Koninklijke Philips N.V., and Biosensors International Group, Ltd.

Key Developments:

In August 2026, Abbott received U.S. FDA De Novo authorization for its Libre Duo 10 Day system, introducing the world's first dual glucose-ketone sensing biowearable to alert people with diabetes to rising ketone levels and prevent diabetic ketoacidosis (DKA).

In June 2026, Dexcom announced FDA clearance expanding its over-the-counter Stelo glucose biosensor indication to children ages 2 and older, alongside plans to launch a redesigned AI-powered mobile app and international expansion into the UK, Australia, and South Korea.

In April 2026, Thermo Fisher agreed to sell its clinical and food-safety microbiology diagnostic segment to private equity firm Astorg for $1.075 billion to focus resources on specialized molecular and analytical biosensing tools.

In February 2026, LifeScan entered into a transformational partnership with biosensor specialist i-SENS to launch a continuous glucose monitoring platform under the OneTouch(R) Vita brand across European markets.

Product Types Covered:

  • Wearable Biosensors
  • Non-Wearable Biosensors

Technologies Covered:

  • Electrochemical Biosensors
  • Optical Biosensors
  • Piezoelectric Biosensors
  • Thermal Biosensors
  • Nanomechanical Biosensors
  • Other Technologies

Applications Covered:

  • Medical Diagnostics
  • Food Safety and Quality Testing
  • Bioprocess and Bioreactor Monitoring
  • Agricultural Applications
  • Environmental Monitoring
  • Other Applications

End Users Covered:

  • Hospitals and Diagnostic Laboratories
  • Home Healthcare
  • Research Laboratories and Academic Institutions
  • Pharmaceutical and Biotechnology Companies
  • Food and Beverage Companies
  • Agricultural Organizations
  • Environmental Monitoring Organizations
  • Security and Biodefense Organizations
  • Other End Users

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Biosensor Market, By Product Type

  • 5.1 Wearable Biosensors
    • 5.1.1 Sensor Patches
    • 5.1.2 Wrist-Worn Biosensors
    • 5.1.3 Smartwatch-Integrated Biosensors
    • 5.1.4 Other Wearable Biosensors
  • 5.2 Non-Wearable Biosensors
    • 5.2.1 Point-of-Care Biosensors
    • 5.2.2 Laboratory-Based Biosensors
    • 5.2.3 Benchtop Biosensors
    • 5.2.4 Embedded Biosensors
    • 5.2.5 Portable and Handheld Biosensors

6 Global Biosensor Market, By Technology

  • 6.1 Electrochemical Biosensors
    • 6.1.1 Amperometric Biosensors
    • 6.1.2 Potentiometric Biosensors
    • 6.1.3 Conductometric Biosensors
    • 6.1.4 Impedimetric Biosensors
  • 6.2 Optical Biosensors
    • 6.2.1 Fluorescence-Based Biosensors
    • 6.2.2 Surface Plasmon Resonance (SPR) Biosensors
    • 6.2.3 Fiber-Optic Biosensors
    • 6.2.4 Colorimetric Biosensors
  • 6.3 Piezoelectric Biosensors
  • 6.4 Thermal Biosensors
  • 6.5 Nanomechanical Biosensors
  • 6.6 Other Technologies

7 Global Biosensor Market, By Application

  • 7.1 Medical Diagnostics
    • 7.1.1 Blood Glucose Monitoring
    • 7.1.2 Cholesterol Testing
    • 7.1.3 Blood Gas Analysis
    • 7.1.4 Pregnancy and Fertility Testing
    • 7.1.5 Infectious Disease Detection
    • 7.1.6 Cancer and Tumor Marker Detection
    • 7.1.7 Cardiovascular Disease Monitoring
    • 7.1.8 Kidney Disease Monitoring
    • 7.1.9 Drug Discovery and Development
    • 7.1.10 Other Medical Applications
  • 7.2 Food Safety and Quality Testing
    • 7.2.1 Food Toxicity Detection
    • 7.2.2 Pathogen Detection
    • 7.2.3 Contaminant Detection
    • 7.2.4 Food Quality Monitoring
  • 7.3 Bioprocess and Bioreactor Monitoring
  • 7.4 Agricultural Applications
    • 7.4.1 Soil Monitoring
    • 7.4.2 Crop Health Monitoring
    • 7.4.3 Plant Disease Detection
    • 7.4.4 Pesticide and Residue Detection
  • 7.5 Environmental Monitoring
    • 7.5.1 Water Quality Monitoring
    • 7.5.2 Air Quality Monitoring
    • 7.5.3 Pollutant Detection
  • 7.6 Other Applications

8 Global Biosensor Market, By End User

  • 8.1 Hospitals and Diagnostic Laboratories
  • 8.2 Home Healthcare
  • 8.3 Research Laboratories and Academic Institutions
  • 8.4 Pharmaceutical and Biotechnology Companies
  • 8.5 Food and Beverage Companies
  • 8.6 Agricultural Organizations
  • 8.7 Environmental Monitoring Organizations
  • 8.8 Security and Biodefense Organizations
  • 8.9 Other End Users

9 Global Biosensor Market, By Geography

  • 9.1 North America
    • 9.1.1 United States
    • 9.1.2 Canada
    • 9.1.3 Mexico
  • 9.2 Europe
    • 9.2.1 United Kingdom
    • 9.2.2 Germany
    • 9.2.3 France
    • 9.2.4 Italy
    • 9.2.5 Spain
    • 9.2.6 Netherlands
    • 9.2.7 Belgium
    • 9.2.8 Sweden
    • 9.2.9 Switzerland
    • 9.2.10 Poland
    • 9.2.11 Rest of Europe
  • 9.3 Asia Pacific
    • 9.3.1 China
    • 9.3.2 Japan
    • 9.3.3 India
    • 9.3.4 South Korea
    • 9.3.5 Australia
    • 9.3.6 Indonesia
    • 9.3.7 Thailand
    • 9.3.8 Malaysia
    • 9.3.9 Singapore
    • 9.3.10 Vietnam
    • 9.3.11 Rest of Asia Pacific
  • 9.4 South America
    • 9.4.1 Brazil
    • 9.4.2 Argentina
    • 9.4.3 Colombia
    • 9.4.4 Chile
    • 9.4.5 Peru
    • 9.4.6 Rest of South America
  • 9.5 Rest of the World (RoW)
    • 9.5.1 Middle East
      • 9.5.1.1 Saudi Arabia
      • 9.5.1.2 United Arab Emirates
      • 9.5.1.3 Qatar
      • 9.5.1.4 Israel
      • 9.5.1.5 Rest of Middle East
    • 9.5.2 Africa
      • 9.5.2.1 South Africa
      • 9.5.2.2 Egypt
      • 9.5.2.3 Morocco
      • 9.5.2.4 Rest of Africa

10 Strategic Market Intelligence

  • 10.1 Industry Value Network and Supply Chain Assessment
  • 10.2 White-Space and Opportunity Mapping
  • 10.3 Product Evolution and Market Life Cycle Analysis
  • 10.4 Channel, Distributor, and Go-to-Market Assessment

11 Industry Developments and Strategic Initiatives

  • 11.1 Mergers and Acquisitions
  • 11.2 Partnerships, Alliances, and Joint Ventures
  • 11.3 New Product Launches and Certifications
  • 11.4 Capacity Expansion and Investments
  • 11.5 Other Strategic Initiatives

12 Company Profiles

  • 12.1 Abbott Laboratories
  • 12.2 F. Hoffmann-La Roche Ltd.
  • 12.3 Medtronic plc
  • 12.4 Bio-Rad Laboratories, Inc.
  • 12.5 Johnson & Johnson
  • 12.6 Siemens Healthineers AG
  • 12.7 Danaher Corporation
  • 12.8 Becton, Dickinson and Company
  • 12.9 Thermo Fisher Scientific Inc.
  • 12.10 Nova Biomedical
  • 12.11 Dexcom, Inc.
  • 12.12 LifeScan, Inc.
  • 12.13 ACON Laboratories, Inc.
  • 12.14 Universal Biosensors, Inc.
  • 12.15 Nemaura Medical, Inc.
  • 12.16 TE Connectivity Ltd.
  • 12.17 Koninklijke Philips N.V.
  • 12.18 Biosensors International Group, Ltd.

List of Tables

  • Table 1 Global Biosensor Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Biosensor Market Outlook, By Product Type (2023-2034) ($MN)
  • Table 3 Global Biosensor Market Outlook, By Wearable Biosensors (2023-2034) ($MN)
  • Table 4 Global Biosensor Market Outlook, By Sensor Patches (2023-2034) ($MN)
  • Table 5 Global Biosensor Market Outlook, By Wrist-Worn Biosensors (2023-2034) ($MN)
  • Table 6 Global Biosensor Market Outlook, By Smartwatch-Integrated Biosensors (2023-2034) ($MN)
  • Table 7 Global Biosensor Market Outlook, By Other Wearable Biosensors (2023-2034) ($MN)
  • Table 8 Global Biosensor Market Outlook, By Non-Wearable Biosensors (2023-2034) ($MN)
  • Table 9 Global Biosensor Market Outlook, By Point-of-Care Biosensors (2023-2034) ($MN)
  • Table 10 Global Biosensor Market Outlook, By Laboratory-Based Biosensors (2023-2034) ($MN)
  • Table 11 Global Biosensor Market Outlook, By Benchtop Biosensors (2023-2034) ($MN)
  • Table 12 Global Biosensor Market Outlook, By Embedded Biosensors (2023-2034) ($MN)
  • Table 13 Global Biosensor Market Outlook, By Portable and Handheld Biosensors (2023-2034) ($MN)
  • Table 14 Global Biosensor Market Outlook, By Technology (2023-2034) ($MN)
  • Table 15 Global Biosensor Market Outlook, By Electrochemical Biosensors (2023-2034) ($MN)
  • Table 16 Global Biosensor Market Outlook, By Amperometric Biosensors (2023-2034) ($MN)
  • Table 17 Global Biosensor Market Outlook, By Potentiometric Biosensors (2023-2034) ($MN)
  • Table 18 Global Biosensor Market Outlook, By Conductometric Biosensors (2023-2034) ($MN)
  • Table 19 Global Biosensor Market Outlook, By Impedimetric Biosensors (2023-2034) ($MN)
  • Table 20 Global Biosensor Market Outlook, By Optical Biosensors (2023-2034) ($MN)
  • Table 21 Global Biosensor Market Outlook, By Fluorescence-Based Biosensors (2023-2034) ($MN)
  • Table 22 Global Biosensor Market Outlook, By Surface Plasmon Resonance (SPR) Biosensors (2023-2034) ($MN)
  • Table 23 Global Biosensor Market Outlook, By Fiber-Optic Biosensors (2023-2034) ($MN)
  • Table 24 Global Biosensor Market Outlook, By Colorimetric Biosensors (2023-2034) ($MN)
  • Table 25 Global Biosensor Market Outlook, By Piezoelectric Biosensors (2023-2034) ($MN)
  • Table 26 Global Biosensor Market Outlook, By Thermal Biosensors (2023-2034) ($MN)
  • Table 27 Global Biosensor Market Outlook, By Nanomechanical Biosensors (2023-2034) ($MN)
  • Table 28 Global Biosensor Market Outlook, By Other Technologies (2023-2034) ($MN)
  • Table 29 Global Biosensor Market Outlook, By Application (2023-2034) ($MN)
  • Table 30 Global Biosensor Market Outlook, By Medical Diagnostics (2023-2034) ($MN)
  • Table 31 Global Biosensor Market Outlook, By Blood Glucose Monitoring (2023-2034) ($MN)
  • Table 32 Global Biosensor Market Outlook, By Cholesterol Testing (2023-2034) ($MN)
  • Table 33 Global Biosensor Market Outlook, By Blood Gas Analysis (2023-2034) ($MN)
  • Table 34 Global Biosensor Market Outlook, By Pregnancy and Fertility Testing (2023-2034) ($MN)
  • Table 35 Global Biosensor Market Outlook, By Infectious Disease Detection (2023-2034) ($MN)
  • Table 36 Global Biosensor Market Outlook, By Cancer and Tumor Marker Detection (2023-2034) ($MN)
  • Table 37 Global Biosensor Market Outlook, By Cardiovascular Disease Monitoring (2023-2034) ($MN)
  • Table 38 Global Biosensor Market Outlook, By Kidney Disease Monitoring (2023-2034) ($MN)
  • Table 39 Global Biosensor Market Outlook, By Drug Discovery and Development (2023-2034) ($MN)
  • Table 40 Global Biosensor Market Outlook, By Other Medical Applications (2023-2034) ($MN)
  • Table 41 Global Biosensor Market Outlook, By Food Safety and Quality Testing (2023-2034) ($MN)
  • Table 42 Global Biosensor Market Outlook, By Food Toxicity Detection (2023-2034) ($MN)
  • Table 43 Global Biosensor Market Outlook, By Pathogen Detection (2023-2034) ($MN)
  • Table 44 Global Biosensor Market Outlook, By Contaminant Detection (2023-2034) ($MN)
  • Table 45 Global Biosensor Market Outlook, By Food Quality Monitoring (2023-2034) ($MN)
  • Table 46 Global Biosensor Market Outlook, By Bioprocess and Bioreactor Monitoring (2023-2034) ($MN)
  • Table 47 Global Biosensor Market Outlook, By Agricultural Applications (2023-2034) ($MN)
  • Table 48 Global Biosensor Market Outlook, By Soil Monitoring (2023-2034) ($MN)
  • Table 49 Global Biosensor Market Outlook, By Crop Health Monitoring (2023-2034) ($MN)
  • Table 50 Global Biosensor Market Outlook, By Plant Disease Detection (2023-2034) ($MN)
  • Table 51 Global Biosensor Market Outlook, By Pesticide and Residue Detection (2023-2034) ($MN)
  • Table 52 Global Biosensor Market Outlook, By Environmental Monitoring (2023-2034) ($MN)
  • Table 53 Global Biosensor Market Outlook, By Water Quality Monitoring (2023-2034) ($MN)
  • Table 54 Global Biosensor Market Outlook, By Air Quality Monitoring (2023-2034) ($MN)
  • Table 55 Global Biosensor Market Outlook, By Pollutant Detection (2023-2034) ($MN)
  • Table 56 Global Biosensor Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 57 Global Biosensor Market Outlook, By End User (2023-2034) ($MN)
  • Table 58 Global Biosensor Market Outlook, By Hospitals and Diagnostic Laboratories (2023-2034) ($MN)
  • Table 59 Global Biosensor Market Outlook, By Home Healthcare (2023-2034) ($MN)
  • Table 60 Global Biosensor Market Outlook, By Research Laboratories and Academic Institutions (2023-2034) ($MN)
  • Table 61 Global Biosensor Market Outlook, By Pharmaceutical and Biotechnology Companies (2023-2034) ($MN)
  • Table 62 Global Biosensor Market Outlook, By Food and Beverage Companies (2023-2034) ($MN)
  • Table 63 Global Biosensor Market Outlook, By Agricultural Organizations (2023-2034) ($MN)
  • Table 64 Global Biosensor Market Outlook, By Environmental Monitoring Organizations (2023-2034) ($MN)
  • Table 65 Global Biosensor Market Outlook, By Security and Biodefense Organizations (2023-2034) ($MN)
  • Table 66 Global Biosensor Market Outlook, By Other End Users (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.